Inspire Medical Systems, Inc. (INSP)
NYSE: INSP · Real-Time Price · USD
58.20
-0.08 (-0.14%)
At close: Aug 13, 2026, 4:00 PM EDT
58.20
0.00 (0.00%)
After-hours: Aug 13, 2026, 7:34 PM EDT
Inspire Medical Systems Revenue
Inspire Medical Systems had revenue of $200.58M in the quarter ending June 30, 2026, a decrease of -7.60%. This brings the company's revenue in the last twelve months to $898.74M, up 4.35% year-over-year. In the year 2025, Inspire Medical Systems had annual revenue of $911.98M with 13.60% growth.
Revenue (ttm)
$898.74M
Revenue Growth
+4.35%
P/S Ratio
1.87
Revenue / Employee
$674,225
Employees
1,333
Market Cap
1.68B
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 911.98M | 109.18M | 13.60% |
| Dec 31, 2024 | 802.80M | 178.01M | 28.49% |
| Dec 31, 2023 | 624.80M | 216.94M | 53.19% |
| Dec 31, 2022 | 407.86M | 174.46M | 74.75% |
| Dec 31, 2021 | 233.39M | 118.01M | 102.28% |
| Dec 31, 2020 | 115.38M | 33.33M | 40.62% |
| Dec 31, 2019 | 82.05M | 31.46M | 62.18% |
| Dec 31, 2018 | 50.59M | 22.03M | 77.10% |
| Dec 31, 2017 | 28.57M | 12.14M | 73.90% |
| Dec 31, 2016 | 16.43M | 8.42M | 105.03% |
| Dec 31, 2015 | 8.01M | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| Enovis | 2.30B |
| Integra LifeSciences Holdings | 1.65B |
| CONMED | 1.37B |
| Tandem Diabetes Care | 1.04B |
| Neogen | 870.40M |
| Alphatec Holdings | 815.05M |
| NovoCure | 699.19M |
| Artivion | 471.47M |
INSP News
- 9 days ago - Inspire Medical price target raised to $60 from $54 at JPMorgan - TheFly
- 9 days ago - Inspire Medical price target raised to $65 from $55 at Mizuho - TheFly
- 9 days ago - Inspire Medical price target raised to $54 from $40 at Evercore ISI - TheFly
- 9 days ago - Inspire Medical price target raised to $45 from $39 at BofA - TheFly
- 9 days ago - Inspire Medical price target raised to $62 from $54 at Truist - TheFly
- 9 days ago - Inspire Medical price target raised to $75 from $65 at Stifel - TheFly
- 9 days ago - Oppenheimer tactically upgrades Inspire Medical despite noisy fundamentals - TheFly
- 9 days ago - Inspire Medical upgraded to Outperform from Perform at Oppenheimer - TheFly